← Browse by Condition
Medical Condition

schizoaffective disorder

Total Trials
6
Recruiting Now
6
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for schizoaffective disorder sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — schizoaffective disorder Clinical Trials

How many clinical trials are currently recruiting for schizoaffective disorder?
ClinicalMetric currently tracks 6 actively recruiting clinical trials for schizoaffective disorder, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 6. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for schizoaffective disorder?
schizoaffective disorder research spans Phase 4 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a schizoaffective disorder clinical trial?
Eligibility criteria for schizoaffective disorder trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 4
2
Top Sponsors
University of Texas Southwestern Medical Center 1 trial
Columbia University 1 trial
Shanghai Mental Health Center 1 trial
Beth Israel Deaconess Medical Center 1 trial
Neurocrine Biosciences 1 trial

Recruiting Clinical Trials

NCT04580134 Phase 4
Recruiting
CLOZAPINE Response in Biotype-1
Enrollment
524 pts
Location
United States
Sponsor
University of Texas Southweste...
View Trial →
NCT05805397
Recruiting
Effectiveness of Motivation Skills Training (MST)
Enrollment
80 pts
Location
United States
Sponsor
Columbia University
View Trial →
NCT06904079
Recruiting
Prediction and Intervention Effect of Rehabilitation Status for Severe Mental Disorder Patients Based on Multimodal Analysis and AI Agents
Enrollment
82 pts
Location
China
Sponsor
Shanghai Mental Health Center
View Trial →
NCT06740383
Recruiting
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
Enrollment
320 pts
Location
United States
Sponsor
Beth Israel Deaconess Medical ...
View Trial →
NCT07105111 Phase 4
Recruiting
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Enrollment
50 pts
Location
United States
Sponsor
Neurocrine Biosciences
View Trial →
NCT05890183
Recruiting
Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode
Enrollment
100 pts
Location
United States
Sponsor
University of California, Los ...
View Trial →

Related Conditions

schizophrenia (6) bipolar 1 disorder (2) severe mental disorder (1) paranoid psychosis (1) bipolar affective disorder (1) mental disorders due to epilepsy (1) mental retardation accompanied by mental disorders (1) schizophrenia spectrum and other psychotic disorders (1) delusional disorder (1) psychosis not otherwise specified (1) early psychosis (1) bipolar disorder (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology